Evaluating Menopause and Women's Telehealth Programs
Evaluating Menopause and Women's Telehealth Programs

To evaluate a menopause or women's telehealth program, first separate menopause-specific care from broader women's health services, then verify the clinical scope and licensed markets, evaluate payout and reversal terms, review claims and creative for accuracy, and compare programs with a consistent checklist.
Menopause telehealth has grown quickly, and programs vary widely in clinical depth. A careful evaluation helps you recommend programs that serve this audience well.
Separate menopause and broader women's care
- Menopause-focused programs: clinicians experienced in perimenopause and menopause, with hormone and non-hormonal options.
- Broader women's health services: may include menopause alongside other services, with less specialization.
Both can be legitimate. Be clear in your content about which one you're recommending.
Verify service scope and markets
- Clinicians' experience in menopause care.
- Treatment range: FDA-approved hormone therapy, non-hormonal prescriptions, lifestyle support, and compounded options only where the clinician and pharmacy decide it's appropriate.
- Intake that covers personal and family history.
- Follow-up schedule.
- Licensed states and pharmacy identified.
Evaluate program terms
- Payable event: completed intake, consultation or first paid month.
- Reversals and their window.
- Recurring credit for memberships.
- Allowed traffic and approval requirements.
Review claims and creative
Do
- A clinician recommends the treatment plan
- Hormone therapy presented as one option among several
- Benefits and risks discussed with a clinician
Avoid
- "Safe," "risk-free," "natural" claims without substantiation
- Promises of relief from specific symptoms or timelines
- Extending FDA's 2026 label changes to all HRT or to compounded hormones
Use the comparison checklist
- Program type identified: menopause-focused or broader
- Clinician experience in menopause described accurately
- Treatment options include FDA-approved and non-hormonal choices
- Intake covers health and family history
- Follow-up schedule defined
- Licensed states and pharmacy listed
- Payable event and reversals documented
- Approved claims avoid "safe" and symptom-relief promises
- Pricing, renewals and cancellation are clear
Beyond menopause: PCOS, contraception and vaginal health
Women's telehealth now reaches well past menopause. Each program type changes what you need to verify:
| Program | Scope to confirm | Claims to avoid |
|---|---|---|
| Menopause and HRT | Clinician training in menopause; labs; follow-up | Risk-free or "natural" hormone claims |
| PCOS | Labs, ongoing care plan, when it refers out | Weight-loss, cycle or fertility promises |
| Contraception | Consultation, prescription delivery, refill schedule | Advising which method to use |
| Vaginal health | Which conditions are treated; when in-person care is needed | Sensational or fear-based messaging |
MarketHealth doesn't accept medication abortion programs. See the women's telehealth category.
Frequently asked questions
Who is this guide for?
Women's health publishers, newsletter owners and creators considering menopause telehealth offers.
What should I gather before I start?
The provider's details, clinical scope, licensed states, pricing and cancellation terms, approved claims and the program's payout terms.
How should I judge the result?
Programs with experienced clinicians, broad treatment options and clear terms earn reader trust and tend to retain patients longer.
Practical guides and programs for health and beauty publishers.
Educational content for marketers and publishers, not medical, legal or financial advice. Examples labeled hypothetical are illustrations, not results. MarketHealth may earn revenue from programs it describes. See our affiliate disclosure and editorial policy.

